XO Life is paving the way for better patient insights
From the leading reporting platform for drug safety to the largest patient insights platform – how we are adding patient insights to healthcare and making data collection alongside every medication and disease the standard. What role does the ImpactMonitor play in this, and how are we shaping the digital health and precision medicine of tomorrow?
What standards are we setting by bringing technology and digitalization to this exchange?
Real-world evidence platform for patient experiences
XO Life has set itself the goal of creating the leading patient insights platform for generating real-world evidence (RWE) for healthcare. To this end, we have created an innovative, multidirectional communication platform that brings patients and healthcare stakeholders together. Healthcare stakeholders can present relevant information to patients or users in a dynamic format. At the same time, relevant information on all aspects of a medication or disease, such as its effectiveness or use, can be systematically collected from patients or users in their everyday lives.
The collected data are pseudonymized, standardized and structured, and made available to the various stakeholders, such as research institutes and manufacturers, for research and development. The aim is to create a large database based on patient experiences collected directly in real-world care settings. The advantage is that specific questions can be answered with relevant answers.
We bring real patient experiences into healthcare and help the healthcare industry better understand its actual end customers – patients.
XO Life – the leading reporting platform for drug safety
After almost two years of development work, we have become the leading platform for patients to report side effects. Our digital reporting platform sets the standard for what direct, user-friendly and, above all, time-saving communication between everyone involved in the reporting process will look like.
Reports are pseudonymized, i.e., without disclosing patients' personal identities, and forwarded digitally and in standardized form to the responsible manufacturers in accordance with European pharmacovigilance guidelines. More than 500 manufacturers already use the platform, more than 100 of which are registered. We place particular emphasis on redesigning drug safety (pharmacovigilance) with a focus on digitalization and user orientation. This is where the major advantages of our solution become apparent: for example, the patient response rate of 60% is around ten times higher than the industry average.
Our innovative communication platform integrates seamlessly into the existing statutory monitoring system for drug safety and supports the entire process. We pay particular attention to redesigning pharmacovigilance in line with digitalization and user orientation. This is another reason why we offer our platform technology as a software-as-a-service solution. Pharmaceutical companies can use it for their own internal reporting channels, e.g., their website, social media channels, input from field sales representatives or call centers.
Digitalizing and automating processes not only improves communication but also enables time savings of up to 95%.
Expanding the platform to cover all patient insights
Our platform technology and partner network have now reached such a level of maturity that we have evolved from a reporting platform for side effects into a real-world evidence platform based on patient insights. For this purpose, standardized questionnaires for capturing patient experiences, known as patient-reported outcomes (PROs), were developed in collaboration with one of Europe's leading research institutes, the PROMIS institute at Charité. In addition, manufacturers also have the option of asking patients and users their own product- or indication-specific questions.
The possibilities that our RWE platform will offer are limitless: for example, we enable the integration of telemedicine services for consulting medical experts. In addition, simple and secure communication channels between manufacturers and consumers can be provided for answering medical inquiries. Safety-related information can also be requested via this channel.
Our web application can be used flexibly, including as a white-label solution, for manufacturers' own product launches, such as introducing newly approved active ingredients to the public.
Via the so-called “ImpactMonitor,” manufacturers can support their patients during medication or therapy in compliance with data protection regulations, provide relevant content and at the same time collect meaningful patient experiences. The possibilities of our patient insights platform are virtually limitless: for example, we enable the integration of telemedicine services, for instance to consult with medical specialists. The ImpactMonitor stands out for its quickly available, structured data. It also opens up many new possibilities for health technology assessment.
Compared with the analog data collection of the past, the ImpactMonitor enables manufacturers to provide patients with digital support that complies with data protection regulations, generating valuable insights.
XO Life is shaping the future of real-world evidence
Following our market entry with a reporting platform for side effects, it is now time to fully realize our vision of a patient insights platform. High data security, data quality and the protection of users' personal data are particularly important to us in this regard.
Our goal is for every patient to receive the best possible digital support through relevant information and the capture of their experiences.
